http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104606230-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
| filingDate | 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104606230-B |
| titleOfInvention | Application of the fat mesenchymal stem cell in terms of lipid-loweringing |
| abstract | The invention discloses a kind of application of fat mesenchymal stem cell in terms of lipid-loweringing, fat mesenchymal stem cell derives from the adipose tissue of health adult, and is separately cultured acquirement using mixing collagenase digestion.Umbilical cord mesenchymal stem cells are obtained using the separation of umbilical cord tissue block creep plate method.Pass through the comparison to UC-MSCs and AD-MSCs in the treatment of db/db mouse model, AD-MSCs can significantly reduce mouse weight and lipids contents, improve Anomalous lipid metablism state, new application direction is brought to eliminate and treating body obesity, or even can also provide new resolving ideas and theoretical foundation for T2DM or metabolic disease. |
| priorityDate | 2015-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 370.